New AI-driven application helps Revenue Cycle Services clients gain faster, clearer visibility into financial performance
CHICAGO–(BUSINESS WIRE)–Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced the launch of a new AI-enabled application for Veradigm Revenue Cycle Services (RCS) clients, designed to deliver faster, deeper revenue cycle insights and strengthen the value of ongoing performance reviews for independent practices.
Independent practices continue to face rising administrative complexity and financial pressure, driven by denials, payment variability, staffing constraints, and limited analytic visibility into what is driving revenue leakage. Veradigm RCS directly addresses these challenges by combining technology, expertise, and operational support to help practices improve cash flow and reduce revenue cycle burden.
Accelerating RCS Value with New AI-Enabled Application
The new AI-enabled application is a web‑based analytics workspace used by Veradigm’s Revenue Cycle Services teams as part of their performance review process with clients. Instead of manually preparing and stitching together reports, analysts can now access an AI‑generated view of denial trends, payment patterns, and operational bottlenecks in a single interface.
The system automatically highlights anomalies, expands audit coverage, and surfaces emerging issues, allowing practices to see what is driving revenue leakage and where intervention is needed.
Veradigm’s new AI-enabled application is expected to reduce manual performance review preparation time by up to 25%, surface denial and payment trends automatically, and apply machine intelligence to expand audit coverage and reduce avoidable rework.
“This application helps practices respond sooner to shifts in payment trends, denials, and operational bottlenecks,” said Tehsin Syed, Chief Product and Technology Officer at Veradigm. “By automating manual steps and strengthening trend identification, we’re giving practices clearer visibility into their financial performance at a more frequent cadence, going from feedback to visualization in minutes.”
Improving Financial Performance with Veradigm Revenue Cycle Services
Veradigm RCS is an end-to-end revenue cycle management solution designed to optimize financial performance for medical practices, with teams supporting everything from communicating with health plans to coding and claims, while integrating into existing electronic health record (EHR) and practice management workflows.
Veradigm RCS consistently delivers top-tier financial outcomes for independent practices, achieving a 98% first-pass clean claims rate, 99% net collections, and 3–5% average revenue improvement in the first year.*
“Over the past 100 days, we have strengthened our senior technology leadership and focused our expert AI team on high-impact client enhancements, starting with revenue cycle,” said Donald Trigg, CEO of Veradigm. “This new application is a clear example of that strategy, applying AI innovation to an already high‑performing revenue cycle solution to help independent practices under increasing financial pressure.”
Veradigm’s new AI-enabled revenue cycle application reflects the company’s continued investment in AI-driven solutions that improve productivity, elevate financial outcomes, and enhance the support clients receive from their RCS teams.
For more information on Veradigm Revenue Cycle Services, visit www.veradigm.com.
*Average results after first 12 months. Veradigm data on file, 2025.
About Veradigm®
Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Our AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system.
© 2026 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or company names are the property of their respective holders, all rights reserved.
Contacts
For more information contact:
Investors:
Jenny Gelinas
312-506-1237
[email protected]
Media:
Amanda Cohen
732-567-7607
[email protected]
